Concepedia

Nigel P. Dolman

NP

8

Publications

574

Citations

8

H-Index

2003

Active since

Affiliations

University of Bristol(Current)

Eli Lilly (United States)

Medical Research Council

Nigel P. Dolman is an author at University of Bristol specializing in medicine, drug discovery, and pharmacology.

Top concepts

Publications per year

2003–2007

8

Publications

8

Crystal Structures of the Kainate Receptor GluR5 Ligand Binding Core Dimer with Novel GluR5-Selective Antagonists

Mark L. Mayer, Alokesh Ghosal, Nigel P. Dolman et al. · Journal of Neuroscience · 2006 · 113 citations · Full text

, , +18

The Different Effects on Recognition Memory of Perirhinal Kainate and NMDA Glutamate Receptor Antagonism: Implications for Underlying Plasticity Mechanisms

G.R. Barker, Elizabeth C. Warburton, Tim Koder et al. · Journal of Neuroscience · 2006 · 108 citations · Full text

, , +18

Characterisation of UBP296: a novel, potent and selective kainate receptor antagonist

Julia C. A. More, Robert Nisticò, Nigel P. Dolman et al. · Neuropharmacology · 2004 · 100 citations

, , +6

Synthesis and Pharmacological Characterization of N<sup>3</sup>-Substituted Willardiine Derivatives:  Role of the Substituent at the 5-Position of the Uracil Ring in the Development of Highly Potent and Selective GLU<sub>K5</sub> Kainate Receptor Antagonists

Nigel P. Dolman, Julia C. A. More, Andrew Alt et al. · Journal of Medicinal Chemistry · 2007 · 72 citations · Full text

, , +14

Synthesis and Pharmacology of Willardiine Derivatives Acting as Antagonists of Kainate Receptors

Nigel P. Dolman, Helen M. Troop, Julia C. A. More et al. · Journal of Medicinal Chemistry · 2005 · 54 citations · Full text

, , +17

Rows per page

1–5 of 8